Skip to main content
Clinical Trials/NL-OMON49820
NL-OMON49820RecruitingNot Applicable

Point-of-care detection of Borrelia antibodies using Sofia 2 Lyme+ FIA: Comparison of finger-prick whole blood assay versus testing in serum or plasma - Sofia 2 Lyme+ testing in finger-stick whole blood

Quidel Corporation0 sites300 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
300

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • - At least 18 years old;
  • - Previous Borrelia antibody testing performed at Innatoss, with known results;
  • - Able and willing to sign the informed consent form.

Exclusion Criteria

  • There are no specific criteria for subjects to be excluded from participation
  • in this study, as long as they adhere to the inclusion criteria mentioned

Investigators

Similar Trials